Neurological Disease and Dementia Strategies
Aries Biotech and the Montine Lab, at Stanford University, are merging their expertise in neurological disease progression and mitigation strategies. Led by Dr. Tom Montine, M.D., PhD, the Montine Lab focuses on the structural and molecular bases of cognitive impairment and dementia through assessment of neuropathology, biomarkers, and pharmacology. Aries Biotech is a neurological disease and dementia biomarker consulting company that provides guidance, data interpretation, and document review for hypothesis-driven research.
Additional information about the Montine Lab may be found at https://www.montinelab.com/index.html.
To learn how we can augment your research and development,
visit Aries Biotech at https://www.ariesbiotechnologies.org
Services are also now available through the university vendor portal.
Comments